Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success
Published inTransplantation, vol. 89, no. 4, p. 465-471
Publication date2010
Abstract
Keywords
- Adult
- Anticoagulants/administration & dosage/therapeutic use
- Antithrombins/analysis
- Blood Glucose/metabolism
- Diabetes Mellitus, Type 1/blood/ surgery
- Drug Administration Schedule
- Female
- Heparin, Low-Molecular-Weight/administration & dosage/ therapeutic use
- Humans
- Hypoglycemic Agents/administration & dosage/therapeutic use
- Insulin/administration & dosage/ therapeutic use
- Islets of Langerhans Transplantation/ physiology
- Male
- Middle Aged
- Multivariate Analysis
- Patient Selection
- Perioperative Care/ methods
- Regression Analysis
- Retrospective Studies
- Thrombin/analysis
- Tissue Donors/ statistics & numerical data
- Treatment Outcome
Affiliation
Research group
Citation (ISO format)
KOH, Angela et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. In: Transplantation, 2010, vol. 89, n° 4, p. 465–471. doi: 10.1097/TP.0b013e3181c478fd
Main files (1)
Article (Published version)
Identifiers
- PID : unige:20692
- DOI : 10.1097/TP.0b013e3181c478fd
- PMID : 20177350
ISSN of the journal0041-1337